Diabetes as a chronic metabolic stressor: Causes, consequences and clinical complications
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus is an endocrine disorder resulting from inadequate insulin release and/or reduced insulin sensitivity. The complications of diabetes are well characterized in peripheral tissues, but there is a growing appreciation that the complications of diabetes extend to the central nervous system (CNS). One of the potential neurological complications of diabetes is cognitive deficits. Interestingly, the structural, electrophysiological, neurochemical and anatomical underpinnings responsible for cognitive deficits in diabetes are strikingly similar to those observed in animals subjected to chronic stress, as well as in patients with stress-related psychiatric illnesses such as major depressive disorder. Since diabetes is a chronic metabolic stressor, this has lead to the suggestion that common mechanistic mediators are responsible for neuroplasticity deficits in both diabetes and depression. Moreover, these common mechanistic mediators may be responsible for the increase the risk of depressive illness in diabetes patients. In view of these observations, the aims of this review are: 1) to describe the neuroplasticity deficits observed in diabetic rodents and patients; 2) to summarize the similarities in the clinical and preclinical studies of depression and diabetes; and 3) to highlight the diabetes-induced neuroplasticity deficits in those brain regions that have been implicated as important pathological centers in depressive illness, namely, the hippocampus, the amygdala and the prefrontal cortex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926 · cited 4×
“Indeed, current estimates suggest that 1 in 4 diabetes patients will experience an episode of depressive illness during their lifetime (Anderson et al., 2001) and identify co-morbid depression as a major long-term complication of diabetes.”
BackgroundInfluentialA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
Herman, J. P., & Cullinan, W. E. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10069-2 · Cited by 2,270 · cited 1×
“One of the hallmark consequences of chronic stress is impairments in the activity of the hypothalamic-pituitary-adrenal (HPA) axis (Herman and Cullinan, 1997).”
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · cited 1×
“…HPA axis dysfunction (Herman et al., 2005), as well as deficits in structural plasticity in the prefrontal cortex, the hippocampus and the amygdala (Sheline et al., 1996; Sheline et al., 1999; Sheline et al., 2003; Sheline et al., 1998; Frodl et al., 2003; Frodl et al., 2002b; Frodl et al., 2002a;…”
BackgroundStress, memory and the amygdala
Roozendaal, B., McEwen, B. S., & Chattarji, S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2651 · Cited by 1,760 · cited 3×
“Depressive illness patients also exhibit deficits in cognitive functions that are attributed to the structural changes in the hippocampus (MacQueen et al., 2003), amygdala (Roozendaal et al., 2009) and prefrontal cortex (Clark et al., 2009).”
BackgroundResultVyas, A., Mitra, R., Shankaranarayana Rao, B. S., & Chattarji, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06810.2002 · Cited by 1,662
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Longstreth, W. T., Manolio, T. A., Arnold, A., Burke, G. L., Bryan, N., Jungreis, C. A., Enright, P. L., O'Leary, D., & Fried, L. (1996) · Stroke · doi:10.1161/01.str.27.8.1274 · Cited by 1,464 · cited 1×
“…patients, such as cortical atrophy and white matter lesions (Manschot et al., 2006; Brands et al., 2007; Manschot et al., 2007; Jongen et al., 2007; de Bresser et al., 2010; Yau et al., 2009; Yau et al., 2010; Akisaki et al., 2006; Soininen et al., 1992; Longstreth et al., 1996; Korf et al., 2007).”
BackgroundSheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 1×
“…et al., 2005), as well as deficits in structural plasticity in the prefrontal cortex, the hippocampus and the amygdala (Sheline et al., 1996; Sheline et al., 1999; Sheline et al., 2003; Sheline et al., 1998; Frodl et al., 2003; Frodl et al., 2002b; Frodl et al., 2002a; MacQueen et al.,…”
BackgroundLimbic system mechanisms of stress regulation: Hypothalamo-pituitary-adrenocortical axis
Herman, J. P., Ostrander, M. M., Mueller, N. K., & Figueiredo, H. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.006 · Cited by 1,322
Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons
Watanabe, Y., Gould, E., & McEwen, B. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)91597-8 · Cited by 1,212 · cited 1×
“In animals, chronic or repeated stress also elicits neuroanatomical changes in the prefrontal cortex [PFC; (Radley et al., 2004)] and hippocampus (Watanabe et al., 1992), features that include atrophy or shrinkage of neurons, as well as decreases in neuronal spine density.”
BackgroundUntreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 1×
“In clinical studies, plasma BDNF levels are decreased in depressive illness patients (Lee et al., 2007), decreases that are reversed by antidepressant treatment (Shimizu et al., 2003).”
BackgroundMood disorders and allostatic load
McEwen, B. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00177-x · Cited by 1,135
Course of illness, hippocampal function, and hippocampal volume in major depression
MacQueen, G. M., Campbell, S., McEwen, B. S., Macdonald, K., Amano, S., Joffe, R. T., Nahmias, C., & Young, L. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337481100 · Cited by 980 · cited 2×
“Depressive illness patients also exhibit deficits in cognitive functions that are attributed to the structural changes in the hippocampus (MacQueen et al., 2003), amygdala (Roozendaal et al., 2009) and prefrontal cortex (Clark et al., 2009).”
BackgroundListon, C., Miller, M. M., Goldwater, D. S., Radley, J. J., Rocher, A. B., Hof, P. R., Morrison, J. H., & McEwen, B. S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1184-06.2006 · Cited by 968
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Intranasal insulin improves cognition and modulates β-amyloid in early AD
Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830
Radley, J. J., Sisti, H. M., Hao, J., Rocher, A. B., McCall, T., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.006 · Cited by 769 · cited 1×
“In animals, chronic or repeated stress also elicits neuroanatomical changes in the prefrontal cortex [PFC; (Radley et al., 2004)] and hippocampus (Watanabe et al., 1992), features that include atrophy or shrinkage of neurons, as well as decreases in neuronal spine density.”
BackgroundThe Effects of Type 1 Diabetes on Cognitive Performance
Brands, A. M. A., Biessels, G. J., de Haan, E. H. F., Kappelle, L. J., & Kessels, R. P. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.726 · Cited by 738 · cited 1×
“…studies that evaluated cognitive performance in diabetes patients and as expected, the magnitude of reported cognitive deficits in diabetes patients spans a very broad spectrum [see (Wrighten et al., 2008; McIntyre et al., 2010; Kodl and Seaquist, 2008; Brands et al., 2005; Biessels et al., 2008)].”
BackgroundLong-term effect of diabetes and its treatment on cognitive function
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa066397 · Cited by 646
Lustman, P. J., Griffith, L. S., Freedland, K. E., Kissel, S. S., & Clouse, R. E. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00005 · Cited by 562
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001021 · Cited by 553
The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function
Awad, N., Gagnon, M., & Messier, C. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490514875 · Cited by 551 · cited 1×
“As with T1DM patients, risk factors such as glycemic control, disease duration and cerebrovascular complications influence the magnitude of cognitive decline in T2DM patients (Awad et al., 2004; Reijmer et al., 2010).”
BackgroundStrachan, M. W. J., Deary, I. J., Ewing, F. M. E., & Frier, B. M. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.438 · Cited by 529 · cited 1×
“Unlike the studies in T1DM patients, most studies suggest that T2DM patients experience cognitive decline [For reviews, see (Strachan et al., 1997; Starr and Convit, 2007; Reijmer et al., 2010; Wrighten et al., 2008)].”
ResultThe source of cerebral insulin
Banks, W. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.040 · Cited by 489 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript to the CNS via a saturable transport system (Banks, 2004) and once inside the brain insulin stimulates and enhances neuroplasticity (Reger and Craft, 2006; Wozniak et al., 1993; Reagan, 2007).”
BackgroundHippocampal damage and memory impairments as possible early brain complications of type 2 diabetes
Gold, S. M., Dziobek, I., Sweat, V., Tirsi, A., Rogers, K., Bruehl, H., Tsui, W., Richardson, S., Javier, E., & Convit, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0602-7 · Cited by 489
Amygdala core nuclei volumes are decreased in recurrent major depression
Sheline, Y. I., Gado, M. H., & Price, J. L. (1998) · NeuroReport · doi:10.1097/00001756-199806220-00021 · Cited by 472 · cited 2×
“It is interesting to note that the changes in the amygdala of T2DM patients are also consistent with some (Sheline et al., 1998), but not all (Frodl et al., 2002a; Frodl et al., 2003) studies in depressive illness patients.”
BackgroundResultAgeing and diabetes: implications for brain function
Biessels, G. J., van der Heide, L. P., Kamal, A., Bleys, R. L. A. W., & Gispen, W. H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01486-3 · Cited by 458
Neurocognitive Mechanisms in Depression: Implications for Treatment
Clark, L., Chamberlain, S. R., & Sahakian, B. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125618 · Cited by 446
Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents
Li, X.-L., Aou, S., Oomura, Y., Hori, N., Fukunaga, K., & Hori, T. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00162-8 · Cited by 440
McEwen, B. S., Chattarji, S., Diamond, D. M., Jay, T. M., Reagan, L. P., Svenningsson, P., & Fuchs, E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.80 · Cited by 406 · cited 1×
“…the emerging appreciation that alterations in the glutamatergic system participate in the pathogenesis of depressive illness (Sanacora et al., 2008; McEwen et al., 2010), as well as the alterations in glutamatergic chemistry and pharmacology observed in T1DM rodents, these data provide an…”
BackgroundSelf-citationDrevets, W. C., Öngür, D., & Price, J. L. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000370 · Cited by 352
RADLEY, J., ROCHER, A., JANSSEN, W., HOF, P., MCEWEN, B., & MORRISON, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.008 · Cited by 323 · cited 12×
“In animals, chronic or repeated stress also elicits neuroanatomical changes in the prefrontal cortex [PFC; (Radley et al., 2004)] and hippocampus (Watanabe et al., 1992), features that include atrophy or shrinkage of neurons, as well as decreases in neuronal spine density.”
BackgroundInfluentialEnlargement of the Amygdala in Patients with a First Episode of Major Depression
Frodl, T., Meisenzahl, E., Zetzsche, T., Bottlender, R., Born, C., Groll, C., Jäger, M., Leinsinger, G., Hahn, K., & Möller, H.-J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01359-2 · Cited by 316 · cited 3×
“It is interesting to note that the changes in the amygdala of T2DM patients are also consistent with some (Sheline et al., 1998), but not all (Frodl et al., 2002a; Frodl et al., 2003) studies in depressive illness patients.”
BackgroundResultAcute Stress-induced Changes in Hippocampal/Prefrontal Circuits in Rats: Effects of Antidepressants
Rocher, C. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg122 · Cited by 307 · cited 13×
“In animals, chronic or repeated stress also elicits neuroanatomical changes in the prefrontal cortex [PFC; (Radley et al., 2004)] and hippocampus (Watanabe et al., 1992), features that include atrophy or shrinkage of neurons, as well as decreases in neuronal spine density.”
BackgroundInfluentialMaroun, M., & Richter-Levin, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04406.2003 · Cited by 293 · cited 1×
“…to morphological plasticity, exposure to chronic stress impairs long-term potentiation (LTP), a form of synaptic plasticity thought to represent a cellular correlate of learning and memory, in the hippocampus (Vouimba et al., 2004) and PFC (Rocher et al., 2004; Maroun and Richter-Levin, 2003).”
BackgroundFrodl, T., Meisenzahl, E. M., Zetzsche, T., Born, C., Jäger, M., Groll, C., Bottlender, R., Leinsinger, G., & Möller, H.-J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01474-9 · Cited by 278
Magariños, A. M., & McEwen, B. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.11056 · Cited by 262 · cited 3×
“As described above, the dendritic atrophy observed in the hippocampus of STZ rats is potentiated by seven days of restraint stress (Magarinos and McEwen, 2000).”
BackgroundNeurocognitive aging and cardiovascular fitness: recent findings and future directions
Colcombe, S. J., Kramer, A. F., McAuley, E., Erickson, K. I., & Scalf, P. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:1:009 · Cited by 214
A look inside the diabetic brain: Contributors to diabetes-induced brain aging
Wrighten, S. A., Piroli, G. G., Grillo, C. A., & Reagan, L. P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.013 · Cited by 195
Self-citationde Kloet, E. R., DeRijk, R. H., & Meijer, O. C. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0403 · Cited by 193
Obese men respond to cognitive but not to catabolic brain insulin signaling
Hallschmid, M., Benedict, C., Schultes, B., Born, J., & Kern, W. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803722 · Cited by 165 · cited 1×
“Interestingly, chronic intranasal insulin administration also improved declarative memory, elevated mood and suppressed plasma cortisol levels in obese individuals (Hallschmid et al., 2008).”
BackgroundRevsin, Y., Rekers, N. V., Louwe, M. C., Saravia, F. E., De Nicola, A. F., de Kloet, E. R., & Oitzl, M. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.136 · Cited by 119 · cited 2×
“STZ rats also exhibit deficits in other forms of hippocampal-dependent behaviors (Alvarez et al., 2009; Revsin et al., 2009; Nitta et al., 2002).”
BackgroundInsulin signaling effects on memory and mood
Reagan, L. P. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.012 · Cited by 118 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript to the CNS via a saturable transport system (Banks, 2004) and once inside the brain insulin stimulates and enhances neuroplasticity (Reger and Craft, 2006; Wozniak et al., 1993; Reagan, 2007).”
BackgroundSelf-citationSCRIBNER, K. A., WALKER, C.-D., CASCIO, C. S., & DALLMAN, M. F. (1991) · Endocrinology · doi:10.1210/endo-129-1-99 · Cited by 112
Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients
Roy, M., Collier, B., & Roy, A. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90106-f · Cited by 107 · cited 3×
“In this regard, elevated basal plasma cortisol levels and impaired responses to a DST were associated with decreases in declarative memory in T2DM patients (Bruehl et al., 2007; Bruehl et al., 2009).”
BackgroundGrillo, C. A., Piroli, G. G., Rosell, D. R., Hoskin, E. K., Mcewen, B. S., & Reagan, L. P. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00343-9 · Cited by 73
Self-citationNeuronal plasticity and antidepressants in the diabetic brain
Beauquis, J., Roig, P., De Nicola, A. F., & Saravia, F. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03983.x · Cited by 16
Cited by
Hippocampal insulin resistance and cognitive dysfunction
Biessels, G. J., & Reagan, L. P. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4019 · Cited by 537
Self-citationInsulin resistance and Parkinson’s disease: A new target for disease modification?
Athauda, D., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 328
Hippocampal Insulin Resistance Impairs Spatial Learning and Synaptic Plasticity
Grillo, C. A., Piroli, G. G., Lawrence, R. C., Wrighten, S. A., Green, A. J., Wilson, S. P., Sakai, R. R., Kelly, S. J., Wilson, M. A., Mott, D. D., et al. (2015) · Diabetes · doi:10.2337/db15-0596 · Cited by 308
Self-citationChronic peripheral inflammation, hippocampal neurogenesis, and behavior
Chesnokova, V., Pechnick, R. N., & Wawrowsky, K. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.01.017 · Cited by 299
Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade
Maiese, K., Chong, Z. Z., Wang, S., & Shang, Y. C. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131113830 · Cited by 109
“Increased weight gain also leads to other disorders that may be a result of metabolic disease, such as coronary artery calcifications and the loss of cognition [68,214].”
Background
Metadata
- Authors
- Reagan, L. P.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 233
- Issue
- 1
- Pages
- 68-78
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2152771413
- Cited by
- 102
- References
- 49
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.